Manufacturing: Page 3


  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    On the Calendar

    Coming Attractions During the 2015 ePharma Summit, Conference Chairman Paul Ivans, who is also founder, president, and CEO of Evolution Road Consulting, will discuss how pharma must adapt to the new healthcare environment and how marketing innovation can help pharma succeed in the new world of he...

    By PharmaVoice Team • Jan. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    South Korea

    Proven R&D capabilities, a strong regulatory system, government support, and a wealth of talent are among the factors that draw pharma companies to South Korea. South Korea, or the Republic of Korea, is an industrialized nation with a strong standing on the world stage. It was the first Asian...

    By Kim Ribbink • Jan. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    2014 PharmaVOICE 100 - Who's on the List by Company

    Who’s on the List — 2014 Indexed by Company Affiliation AbelsonTaylor – Dr. Jeffrey Berg Advanced Clinical LLC – Susan Seroskie Advanced Clinical LLC – Julie Ross Baxter Healthcare Corp. – John Glasspool BBK Worldwide – Aaron Fleishman BioClinica Inc. – Dr. Boaz Mendzelevski Biogen Idec – Dr. Kat...

    By Robin Robinson • July 28, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    UpFront

    INDUSTRY at Large Kowa and Football Player Help those with High Cholesterol Kowa Pharmaceuticals America has announced a partnership with Kurt Warner, Super Bowl winner and two-time NFL MVP, and his wife Brenda, to launch First and Goal, a national education initiative to help people prioritize h...

    By Denise Myshko • July 28, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Letter from the Editor

    The 2014 PharmaVOICE 100 The PharmaVOICE 100 Turns 10! It’s hard to believe that 10 years after the vision for this issue was captured on the back of a napkin during a long flight delay, we have now profiled 1,000 of the industry’s most inspirational and motivational individuals making this issue...

    By Taren Grom • July 28, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Malaysia Focuses on Growth with Healthcare a Top Priority

    Malaysia presents an attractive market to pharmaceutical companies thanks to growing government support, good infrastructure, and a trusted manufacturing environment. Malaysia is a federal constitutional monarchy with a population of about 29 million and an open and growing economy. According to ...

    By Kim Ribbink • April 28, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Year in Preview: Corporate Trends: Getting Down to Business

    “The most critical business ­objective is to ensure our ­industry’s value and ­importance to biomedical innovation is ­embraced and guarded. " Nick Colucci Publicis Healthcare Group “The industry needs to ­optimize clinical trial operations through technology. " Eric Silberstein TrialNetworks “Th...

    By PharmaVoice Team • Nov. 12, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Mentoring: Effective Programs Yield Successful Employees

    Mentoring: Effective Programs Yield Successful Employees The industry digs into career development programs to improve employee engagement. Mention the word mentoring and you might get some eye rolls — the practice is not always viewed in a favorable light. All it takes is one bad mentoring exper...

    By PharmaVoice Team • Sept. 27, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    On the Calendar

    The Calendar The 2013 mHealth Summit, being held at the Gaylord National Resort and Conference Center, near Washington, D.C., is an international forum connecting the mobile health ecosystem for mHealth research, education, thought leadership, exhibits, and action-provoking panel discussions. The...

    By PharmaVoice Team • Sept. 27, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    PharmaVOICE 100 - Who's on the List by Section

    The Commanders & Chiefs David Berry Pronutria Damian Braga Sanofi Pasteur David Bruggeman Clinical Research Advantage Walter Capone The Multiple Myeloma Research Foundation Steve Collis AmerisourceBergen Corp. Nick Colucci Publicis Healthcare Communications Group Jim Curtis Remedy Health Medi...

    By Taren Grom • July 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    On the Calendar

    May 16-17 Thought Leader Engagement, the Role of Medical Affairs and Medical Science Liaisons in the Era of Healthcare ­Reform Hyatt at the Bellevue, Philadelphia World Congress, worldcongress.com May 20-21 2nd Annual Quality Assurance in Pharmaceutical Manufacturing Conference Alexandria, Va. Q1...

    By Heather Hummel • April 26, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Courageous Leadership

    Courageous Leadership By Robin Robinson To navigate through disruptive change, the industry’s leaders need to be open, strong, and have the willingness to try something new. In its From Vision to Decision 2020 report, PricewaterhouseCoopers (PwC) analysts say successful innovation requires strong...

    By Robin Robinson • Feb. 27, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    SHOWCASE FEATURE: Outsourcing: Outsourcing For Efficiency

    Outsourcing for Efficiency For many sponsor companies in the life-sciences industry engaging with outsourcing partners — from the clinic to the market — is imperative if they want to drive efficiencies in time, money, and personnel as well as innovation. Life-sciences companies can reap the many ...

    By Taren Grom • Jan. 28, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    C-Suite: Specialty Pharma

    Specialty Pharma Targeted Opportunities C-Suite: Specialty Pharma By Taren Grom The growing U.S. specialty pharmaceuticals market is comprised of more than 90 companies marketing more than 550 prescription pharmaceutical products, according to MCD Group, and dozens of therapeutic categories, incl...

    By Taren Grom • Jan. 28, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Saudi Arabia: Oil Wealth Opens Doors to Health and Life Sciences

    Saudi Arabia: Oil Wealth Opens Doors to Health and Life Sciences By Kim Ribbink Its wealth, growing population, investment in health and the life sciences, and high rates of diseases such as diabetes, make Saudi Arabia an exciting market for pharma companies. Saudi Arabia is perhaps best known fo...

    By Kim Ribbink • Jan. 28, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Insights from the C-Suite: Pharmaceutical Companies

    Insights from the C-Suite: Pharmaceutical CompaniesThe pharmaceutical industry is facing a number of well-publicized challenges: increasing generic competition, pricing pressures, innovation hurdles, Wall Street scrutiny, etc. C-suite pharmaceutical executives who were also featured in the Pharma...

    By Taren Grom • Aug. 30, 2012
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Coming of Age: India Grows in Stature

    India’s pharmaceutical industry is now the third largest in the world in terms of volume and stands 14th in terms of value. The country’s pharmaceutical market is expected to reach $55 billion in 2020 from $12.6 billion in 2009. And with a population of 1.1 billion, India is predicted to be the m...

    By Kim Ribbink • Aug. 30, 2012
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Talent Pool

    Talent Pool executive appointments and promotions in the healthcare industry Pharmaceutical POOL Dr. Franck BARRAT­ Roche Broadens Inflammatory ­Expertise Franck Barrat, Ph.D., has joined Roche’s inflammation discovery and translational areas (DTA) as a distinguished scientist. Dr. Barrat brings ...

    By PharmaVoice Team • July 28, 2012
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    On the Calendar

    The Calendar Industry Events and Conferences, including SPECIAL DISCOUNTS Coming ATTRACTIONS Two colocated conferences produced by The Conference Forum will be held in Boston September 13-14. The 3rd Annual Executing Global Clinical Trials will focus on the strategies that will provide increased ...

    By PharmaVoice Team • July 28, 2012
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    SHOWCASE FEATURE: Clinical Trial Solutions

    SHOWCASE FEATURE: Clinical Trial Solutions Trials Without Tribulations By Carolyn Gretton As clinical studies become more global and increasingly complex, sponsors are striving to improve ­efficiencies, gain increased access to patients and investigators, and better integrate R&D competencies...

    By PharmaVoice Team • May 29, 2012
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Global Supply Chain: Information Drives Transformation

    Robin Robinson Connecting directly with ­patients will be a new role for the supply chain ­function. There are a number of factors that are expected to reshape global supply chain processes, but none more than the onset of comparative effectiveness and the need to monitor and document patient out...

    By Robin Robinson • April 27, 2012
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    The Sun Keeps Rising on Japan's Pharma Industry

    Kim Ribbink Japan’s numerous universities and research institutions, cutting-edge research, ­­ state-of-the-art technology, and high-quality manufacturing facilities are the hallmarks of a leading market for the pharmaceutical industry. Japan is one of the world’s lead developers of pharmaceutica...

    By Kim Ribbink • April 27, 2012
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Market Capitalization

    Effective marketing is at the heart of success for pharmaceutical brands and companies. And to get to the promised land, pharmaceutical companies around the globe are leveraging traditional and new media to sell and market their products. Most companies are faced with balancing myriad tactics to ...

    By Taren Grom • Feb. 26, 2012
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Creating the Message in Phase II Trials

    Decisions made in Phase II trials can have an impact on the development and marketing program for new products, and experts say Phase II is becoming a critical stage for planning the potential launch and marketing of products. Bringing agencies in earlier in the process makes a lot of sense, says...

    By Denise Myshko • Feb. 26, 2012
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    What's Ahead for Biosimilars

    Denise Myshko Uncertainty lies ahead for the biosimilar market, as manufacturers await FDA guidance. Biosimilars could represent a multi-billion dollar market in the United States, although some questions remain, including the uptake by physicians and payers, pricing of biosimilars, and how the F...

    By Denise Myshko • Jan. 27, 2012